help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koivisto, P.
Right arrow Articles by Kallioniemi, O. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koivisto, P.
Right arrow Articles by Kallioniemi, O. P.

American Journal of Pathology, Vol 152, 1-9, Copyright © 1998 by American Society for Investigative Pathology

REVIEWS

Androgen receptor gene and hormonal therapy failure of prostate cancer

P Koivisto, M Kolmer, T Visakorpi and OP Kallioniemi
Laboratory of Cancer Genetics, Tampere University Hospital and Institute of Medical Technology, University of Tampere, Finland.

Androgen receptor (AR) is a nuclear transcription factor that binds male sex steroids and mediates the biological effects of these hormones to the target cells, such as the epithelial cells of the prostate gland, by activating transcription of androgen-dependent genes. Withdrawal of androgens or the peripheral blockade of androgen action remain the critical therapeutic options for the treatment of advanced prostate cancer. However, after initial regression, many prostate cancers become hormone refractory and progress further with eventual fatal outcome. Understanding the mechanisms of tumor progression and endocrine therapy failure is an important goal. A large number of different molecular mechanisms may be responsible for development of hormone-refractory recurrent tumors. Many of these involve the AR gene and its complex downstream signaling pathways. The role of AR mutations and altered transactivational properties of the receptor have received the most attention as causative factors for progression. However, other mechanisms, such as AR gene amplification and overexpression or increased local bioconversion of androgens, may contribute to the development of progression by mechanisms that involve androgen- dependent cell growth. Here we review the role of the AR gene and its putative downstream effector pathways during human prostate cancer progression and endocrine therapy failure.


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
R. P. Singh, G. Deep, M.-J. Blouin, M. N. Pollak, and R. Agarwal
Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft
Carcinogenesis, December 1, 2007; 28(12): 2567 - 2574.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
T.-H. Li, H. Zhao, Y. Peng, J. Beliakoff, J. D. Brooks, and Z. Sun
A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells
Nucleic Acids Res., April 10, 2007; (2007) gkm198v1.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
R. Veluri, R. P. Singh, Z. Liu, J. A. Thompson, R. Agarwal, and C. Agarwal
Fractionation of grape seed extract and identification of gallic acid as one of the major active constituents causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cells
Carcinogenesis, July 1, 2006; 27(7): 1445 - 1453.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. He, R. T. Gampe Jr., A. T. Hnat, J. L. Faggart, J. T. Minges, F. S. French, and E. M. Wilson
Probing the Functional Link between Androgen Receptor Coactivator and Ligand-binding Sites in Prostate Cancer and Androgen Insensitivity
J. Biol. Chem., March 10, 2006; 281(10): 6648 - 6663.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Saleem, M.-H. Kweon, J.-M. Yun, V. M. Adhami, N. Khan, D. N. Syed, and H. Mukhtar
A Novel Dietary Triterpene Lupeol Induces Fas-Mediated Apoptotic Death of Androgen-Sensitive Prostate Cancer Cells and Inhibits Tumor Growth in a Xenograft Model
Cancer Res., December 1, 2005; 65(23): 11203 - 11213.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Y. Dong, H. Zhang, A. C. Gao, J. R. Marshall, and C. Ip
Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers
Mol. Cancer Ther., July 1, 2005; 4(7): 1047 - 1055.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Sarfaraz, F. Afaq, V. M. Adhami, and H. Mukhtar
Cannabinoid Receptor as a Novel Target for the Treatment of Prostate Cancer
Cancer Res., March 1, 2005; 65(5): 1635 - 1641.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Yim, R. P. Singh, C. Agarwal, S. Lee, H. Chi, and R. Agarwal
A Novel Anticancer Agent, Decursin, Induces G1 Arrest and Apoptosis in Human Prostate Carcinoma Cells
Cancer Res., February 1, 2005; 65(3): 1035 - 1044.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. Han, G. Buchanan, M. Ittmann, J. M. Harris, X. Yu, F. J. DeMayo, W. Tilley, and N. M. Greenberg
Mutation of the androgen receptor causes oncogenic transformation of the prostate
PNAS, January 25, 2005; 102(4): 1151 - 1156.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. M. Velasco, K. A. Gillis, Y. Li, E. L. Brown, T. M. Sadler, M. Achilleos, L. M. Greenberger, P. Frost, W. Bai, and Y. Zhang
Identification and Validation of Novel Androgen-Regulated Genes in Prostate Cancer
Endocrinology, August 1, 2004; 145(8): 3913 - 3924.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Tong and H.-H. Tai
Synergistic Induction of the Nicotinamide Adenine Dinucleotide-Linked 15-Hydroxyprostaglandin Dehydrogenase by an Androgen and Interleukin-6 or Forskolin in Human Prostate Cancer Cells
Endocrinology, May 1, 2004; 145(5): 2141 - 2147.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Oram, F. Jiang, X. Cai, R. Haleem, Z. Dincer, and Z. Wang
Identification and Characterization of an Androgen-Responsive Gene Encoding an Aci-Reductone Dioxygenase-Like Protein in the Rat Prostate
Endocrinology, April 1, 2004; 145(4): 1933 - 1942.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Rahman, H. Miyamoto, and C. Chang
Androgen Receptor Coregulators in Prostate Cancer: Mechanisms and Clinical Implications
Clin. Cancer Res., April 1, 2004; 10(7): 2208 - 2219.
[Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. W. Gregory, X. Fei, L. A. Ponguta, B. He, H. M. Bill, F. S. French, and E. M. Wilson
Epidermal Growth Factor Increases Coactivation of the Androgen Receptor in Recurrent Prostate Cancer
J. Biol. Chem., February 20, 2004; 279(8): 7119 - 7130.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
X. Wang, H. Deng, I. Basu, and L. Zhu
Induction of Androgen Receptor-Dependent Apoptosis in Prostate Cancer Cells by the Retinoblastoma Protein
Cancer Res., February 15, 2004; 64(4): 1377 - 1385.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. P. Singh, G. Sharma, G. U. Mallikarjuna, S. Dhanalakshmi, C. Agarwal, and R. Agarwal
In Vivo Suppression of Hormone-Refractory Prostate Cancer Growth by Inositol Hexaphosphate: Induction of Insulin-Like Growth Factor Binding Protein-3 and Inhibition of Vascular Endothelial Growth Factor
Clin. Cancer Res., January 1, 2004; 10(1): 244 - 250.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Hara, K. Nakamura, H. Araki, M. Kusaka, and M. Yamaoka
Enhanced Androgen Receptor Signaling Correlates with the Androgen-refractory Growth in a Newly Established MDA PCa 2b-hr Human Prostate Cancer Cell Subline
Cancer Res., September 1, 2003; 63(17): 5622 - 5628.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
R. P. Singh, C. Agarwal, and R. Agarwal
Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes
Carcinogenesis, March 1, 2003; 24(3): 555 - 563.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C. Agarwal, R. P. Singh, and R. Agarwal
Grape seed extract induces apoptotic death of human prostate carcinoma DU145 cells via caspases activation accompanied by dissipation of mitochondrial membrane potential and cytochrome c release
Carcinogenesis, November 1, 2002; 23(11): 1869 - 1876.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
D. Karan, D. L. Kelly, A. Rizzino, M.-F. Lin, and S. K. Batra
Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells
Carcinogenesis, June 1, 2002; 23(6): 967 - 976.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
Z.-Q. Huang, J. Li, and J. Wong
AR Possesses an Intrinsic Hormone-Independent Transcriptional Activity
Mol. Endocrinol., May 1, 2002; 16(5): 924 - 937.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. Sasaki, Y. Tanaka, G. Perinchery, A. Dharia, I. Kotcherguina, S. i. Fujimoto, and R. Dahiya
Methylation and Inactivation of Estrogen, Progesterone, and Androgen Receptors in Prostate Cancer
J Natl Cancer Inst, March 6, 2002; 94(5): 384 - 390.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D. Kim, C. W. Gregory, F. S. French, G. J. Smith, and J. L. Mohler
Androgen Receptor Expression and Cellular Proliferation During Transition from Androgen-Dependent to Recurrent Growth after Castration in the CWR22 Prostate Cancer Xenograft
Am. J. Pathol., January 1, 2002; 160(1): 219 - 226.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C.-Y. Chang, P. J. Walther, and D. P. McDonnell
Glucocorticoids Manifest Androgenic Activity in a Cell Line Derived from a Metastatic Prostate Cancer
Cancer Res., December 1, 2001; 61(24): 8712 - 8717.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
M. E. Grossmann, H. Huang, and D. J. Tindall
Androgen Receptor Signaling in Androgen-Refractory Prostate Cancer
J Natl Cancer Inst, November 21, 2001; 93(22): 1687 - 1697.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. Karan, B. M. Schmied, B. J. Dave, U. A. Wittel, M.-F. Lin, and S. K. Batra
Decreased Androgen-responsive Growth of Human Prostate Cancer Is Associated with Increased Genetic Alterations
Clin. Cancer Res., November 1, 2001; 7(11): 3472 - 3480.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Long. G. Wang, L. Ossowski, and A. C. Ferrari
Overexpressed Androgen Receptor Linked to p21WAF1 Silencing May Be Responsible for Androgen Independence and Resistance to Apoptosis of a Prostate Cancer Cell Line
Cancer Res., October 1, 2001; 61(20): 7544 - 7551.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. M. Henshall, D. I. Quinn, C. S. Lee, D. R. Head, D. Golovsky, P. C. Brenner, W. Delprado, P. D. Stricker, J. J. Grygiel, and R. L. Sutherland
Altered Expression of Androgen Receptor in the Malignant Epithelium and Adjacent Stroma Is Associated with Early Relapse in Prostate Cancer
Cancer Res., January 1, 2001; 61(2): 423 - 427.
[Abstract] [Full Text]

Home page
 Genes Dev.Home page
C. Abate-Shen and M. M. Shen
Molecular genetics of prostate cancer
Genes & Dev., October 1, 2000; 14(19): 2410 - 2434.
[Full Text]

Home page
 Cancer Res.Home page
H. Kinoshita, Y. Shi, C. Sandefur, L. F. Meisner, C. Chang, A. Choon, C. R. Reznikoff, G. S. Bova, A. Friedl, and D. F. Jarrard
Methylation of the Androgen Receptor Minimal Promoter Silences Transcription in Human Prostate Cancer
Cancer Res., July 1, 2000; 60(13): 3623 - 3630.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
J. W. Gray and C. Collins
Genome changes and gene expression in human solid tumors
Carcinogenesis, March 1, 2000; 21(3): 443 - 452.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Jongsma, M. H. Oomen, M. A. Noordzij, W. M. Van Weerden, G. J. M. Martens, T. H. van der Kwast, F. H. Schröder, and G. J. van Steenbrugge
Androgen Deprivation of the Prohormone Convertase-310 Human Prostate Cancer Model System Induces Neuroendocrine Differentiation
Cancer Res., February 1, 2000; 60(3): 741 - 748.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
M. Marcelli, M. Ittmann, S. Mariani, R. Sutherland, R. Nigam, L. Murthy, Y. Zhao, D. DiConcini, E. Puxeddu, A. Esen, et al.
Androgen Receptor Mutations in Prostate Cancer
Cancer Res., February 1, 2000; 60(4): 944 - 949.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
P. A. Koivisto, J. Schleutker, H. Helin, C. E.-v. Eekelen, O.-P. Kallioniemi, and J. Trapman
Androgen Receptor Gene Alterations and Chromosomal Gains and Losses in Prostate Carcinomas Appearing During Finasteride Treatment for Benign Prostatic Hyperplasia
Clin. Cancer Res., November 1, 1999; 5(11): 3578 - 3582.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. J. Advani, S.-M. Chung, S. Y. Yan, G. Y. Gillespie, J. M. Markert, R. J. Whitley, B. Roizman, and R. R. Weichselbaum
Replication-competent, Nonneuroinvasive Genetically Engineered Herpes Virus Is Highly Effective in the Treatment of Therapy-resistant Experimental Human Tumors
Cancer Res., May 1, 1999; 59(9): 2055 - 2058.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Lu and M. Danielsen
Differential Regulation of Androgen and Glucocorticoid Receptors by Retinoblastoma Protein
J. Biol. Chem., November 20, 1998; 273(47): 31528 - 31533.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
C. Lopez-Otin and E. P. Diamandis
Breast and Prostate Cancer: An Analysis of Common Epidemiological, Genetic, and Biochemical Features
Endocr. Rev., August 1, 1998; 19(4): 365 - 396.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Society for Investigative Pathology.